Loew Caroline
- SEC CIK
- 0001989488
No open-market purchases or sales filed in the past year.
Current role at each company
- MURA Mural Oncology plcChief Executive Officeras of Dec 5, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Loew Caroline as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2025 (view filing) | Jul 7 | 2 days | Loew CarolineChief Executive Officer | SSale | −12.5K | $2.43 | −$30.5K | −4.1%293.1K after | 10b5-1 |
| Mar 5, 2025 (view filing) | Mar 4 | 1 day | Loew CarolineChief Executive Officer | SSale | −4.31K | $3.36 | −$14.5K | −1.4%305.6K after | 10b5-1 |
| Dec 18, 2024 (view filing) | Dec 17 | 1 day | Loew CarolineChief Executive Officer | SSale | −2.76K | $3.40 | −$9.39K | −1.1%237.6K after | 10b5-1 |
| Jul 8, 2024 (view filing) | Jul 8 | Same day | Loew CarolineChief Executive Officer | SSale | −12.5K | $2.91 | −$36.5K | −5.0%240.4K after | 10b5-1 |